Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the Pre-Trastuzumab and Trastuzumab eras

PURPOSE: To evaluate the survival of patients with human epidermal growth factor receptor 2 (HER2) positive and negative metastatic breast cancer irradiated for brain metastases before and after the availability of trastuzumab (T). MATERIALS AND METHODS: Women diagnosed with brain metastasis from br...

Descripción completa

Detalles Bibliográficos
Autores principales: Karam, Irene, Hamilton, Sarah, Nichol, Alan, Woods, Ryan, Speers, Caroline, Kennecke, Hagen, Tyldesley, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582534/
https://www.ncbi.nlm.nih.gov/pubmed/23302543
http://dx.doi.org/10.1186/1748-717X-8-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582534/
https://www.ncbi.nlm.nih.gov/pubmed/23302543
http://dx.doi.org/10.1186/1748-717X-8-12

Ejemplares similares